Tom Mirga

Colorado Lawmakers Pass 340B Anti-discrimination Bill

In Legislative, StateMay 19, 2022188 Views

Colorado lawmakers voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

The Colorado General Assembly has voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

Please Login or Become a Paid

…

U.S. Uninsured Rate Dipped Slightly in 2021 to 9.2% but Rates for Hispanics and Blacks Remain High

In Federal, Research/ReportsMay 19, 202260 Views

Tom Mirga

The U.S. uninsured rate fell slightly in 2021 to 9.2%, down from 9.7% in 2020, new data from the National Center for Health Statistics (NCHS) show.

The U.S. uninsured rate fell slightly in 2021 to 9.2% (about 30 million people), down from 9.7% (about 31.6 million people) in 2020, the National Center for Health Statistics (NCHS) reports.

Please Login or

…

25 States Say Drug Companies’ 340B Contract Pharmacy Actions Are Illegal and Harm Public Health

In Federal, JudicialMay 17, 2022474 Views

Tom Mirga

An excerpt from one of the two friend of the court briefs that 25 states filed in pivotal 340B contract pharmacy litigation in federal appeals courts.

Drug manufacturers’ conditions on 340B pricing when covered entities use contract pharmacies violate federal law and ultimately diminish states’ public health efforts, 25 states told two federal appeals courts yesterday.

Please Login or Become

…

GOP-aligned Think Tank Alleges that 340B Expansions Contributed to Drug Spending Spurts

In Research/ReportsMay 17, 2022283 Views

Tom Mirga and Ted Slafsky

The American Action Forum says "it is worthwhile to consider whether" there is a link between the implementation of 340B policies and upswings in retail drug spending. A drug policy experts who found that that inflation penalties in the 340B program were associated with lower annual drug price increases says AAF's analysis "is specious at best."

An American Action Forum (AAF) data analysis that connects increases in consumer drug spending with the introduction of 340B drug discount and Medicaid drug rebate program policies “is spurious at best,” says an expert on prescription drug costs

…

HRSA Announces 340B Enrollment Flexibilities in Fire-Ravished New Mexico

In Federal, RegulatoryMay 17, 2022173 Views

Tom Mirga

HRSA has announced 340B program enrollment flexibilities in New Mexico, which is coping with the biggest wildfire in state history.

The U.S. Health Resources and Services Administration (HRSA) yesterday announced 340B program enrollment flexibilities in New Mexico due to the declaration of a public health emergency in the state.

Please Login or Become a

…

25 States File Joint Briefs Backing HHS and HRSA in 340B Contract Pharmacy Cases

In Federal, Judicial, News AlertMay 16, 20221291 Views

Tom Mirga

Connecticut Attorney General William Tong (D) led the coalition of states backing the federal government in 340B contract pharmacy cases before federal appeals courts.

Twenty-five states are backing the federal government in litigation before two federal appeals courts over drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber

…

Mallinckrodt Is the Third Drug Company This Month to Announce Refunds for 340B Overcharges

In Federal, Pharma Industry, RegulatoryMay 12, 2022343 Views

Tom Mirga

Mallinckrodt's SpecGx subsidiary is providing refunds for 340B overcharges on 22 NDCs for purchases from Q3 2019 through Q2 2020.

Drug manufacturer Mallinckrodt’s SpecGx generic pharmaceutical subsidiary is providing refunds for 340B overcharges on 22 NDCs for purchases from Q3 2019 through Q2 2020.

Please Login or Become a Paid Subscriber to View this

…

340B Providers Lose their Biggest GOP Ally in U.S. House

In Federal, LegislativeMay 12, 2022307 Views

Tom Mirga and Ted Slafsky

U.S. Rep. David McKinley (R-W.Va.) lost his GOP primary election this week. It's a huge blow for 340B entities that have relied on his help in Congress for years.

In a major blow to the 340B provider community, U.S. Rep. David McKinley, the leading voice for the 340B program in the House Republican caucus, was defeated Tuesday in the West Virginia Republican primary. McKinley will remain in

…

Drug Makers Ask Michigan Lawmakers to Erase Section from New 340B State Law

In Legislative, Pharma Industry, StateMay 12, 2022438 Views

Tom Mirga

Michigan 340B hospitals say drug manufacturers are lobbying state lawmakers to erase language from a new state law that the hospitals say stops the drug makers from imposing claims submission requirements as a condition for 340B pricing.

Drug manufacturers are asking Michigan state legislators to erase language in a new state law that Michigan hospitals say bars the companies from withholding 340B pricing if a covered entity refuses to hand over its contract pharmacy claims

…

Letting Pharma Put Strings on 340B is Letting Fox Guard Henhouse, Feds Tell Appeals Courts

In Federal, JudicialMay 10, 2022491 Views

Tom Mirga

The DOJ told federal appeals courts in Philadelphia and Washington, D.C., that HHS was right to tell drug manufacturers their conditions on 340B contract pharmacy are illegal and must end.

Letting drug manufacturers put conditions on 340B drug discounts “would be akin to letting the fox guard the henhouse,” the U.S. Justice Department (DOJ) told federal appeals courts in Philadelphia and Washington, D.C., last night in a pair

…